Whether you are considering selling your practice, looking to buy one, or simply want to understand what your practice is worth, knowing how dental practice valuation works is essential. The methods used vary, and understanding them helps you make informed decisions and avoid being anchored to a misleading number.
In this guide we walk through the approaches used to value UK dental practices in 2025/26, explain why one method dominates, show what actually moves the figure, and flag the rules of thumb that lead sellers and buyers astray.
The Primary Method: Normalised EBITDA Times a Multiple
For an established, profitable practice the market settles on one core approach. You take the practice's normalised EBITDA and multiply it by a market multiple. Everything else is a cross-check or a special case.
EBITDA stands for earnings before interest, tax, depreciation, and amortisation, which is broadly the practice's operating profit. The word that matters most, though, is "normalised". Reported profit in a set of dental accounts rarely reflects what a new owner would actually earn, because the current owner's pay, pension, personal motoring, and one-off costs all sit inside the figures. Normalisation strips those out and replaces the owner's clinical and management input with a market-rate cost, so the result is the sustainable profit a buyer can rely on. We cover the adjustments in detail in our guide to normalising EBITDA for a dental practice, and it is worth reading before you put any number on your practice.
Once you have a defensible normalised EBITDA, the multiple does the rest of the work. The multiple is not plucked from the air. It reflects how much risk a buyer is taking on and how much they want the practice.
What Drives the Multiple
The multiple expands or contracts according to the qualities a buyer cares about most:
- NHS or private mix. Private fee income carries better margins and is not exposed to a fixed contract, so it tends to support a higher multiple. NHS income is more predictable but capped and harder to grow.
- Location and local demand. A practice in an area with strong patient demand and limited competing surgeries attracts more buyers, which lifts the multiple.
- Patient list quality and stability. A loyal, active list with good recall data lowers the buyer's risk of attrition after completion.
- Profit margin and trend. Three years of stable or growing normalised margins justify the top of the range, while a declining trend pulls it down.
- Lease, premises, and equipment. A long secure lease and modern, well-maintained surgeries reduce post-sale capital risk.
- Owner dependence. The less the practice relies on the seller's personal relationships, the safer the earnings look to a buyer.
Indicative Multiple Ranges by Practice Type (2025/26)
The table below sets out the indicative ranges seen in the UK market in 2025/26. Treat these as ranges, never a single number, and remember that the drivers above can move any individual practice up or down within or beyond its band. Corporate and group buyers chasing scale or geography sometimes pay a strategic premium above the private range.
| Practice type | Typical profile | Indicative multiple of normalised EBITDA |
|---|---|---|
| NHS-heavy, single-handed, lower-demand region | One surgery, mostly UDA income, limited private upside, fewer competing buyers | ~0.6 to 0.9x |
| Mixed, multi-surgery, normal-demand area | Several surgeries, balanced NHS and private income, stable list and team | ~0.9 to 1.2x |
| Private-focused, high-demand area | Mostly private fee income, strong margins, growth headroom, multiple interested buyers | ~1.1 to 1.4x |
| Corporate or strategic acquisition | Practice that fits a group's expansion or fills a geographic gap | Can exceed the private range |
These bands are why presenting clean, normalised figures matters so much. The same practice can land at very different prices depending on whether the buyer can see a reliable EBITDA and a low-risk story. Good record-keeping, ideally backed by accounts that clearly separate the NHS and private income streams, supports the upper end of the range.
Goodwill Versus Tangible Assets
A valuation produces a total enterprise value, but the price is then split between two components: goodwill and tangible assets. Goodwill is the intangible value of the patient list, reputation, contract, and trading history. Tangible assets are the chairs, X-ray units, fixtures, fittings, and leasehold improvements.
For most UK dental practices, goodwill makes up roughly 60 to 80 percent of the total price, with tangible assets accounting for the balance. The exact split depends on the practice type and how much recent equipment investment sits on the balance sheet. A newer, heavily fitted-out surgery carries a larger tangible slice, while an established private list with modest kit is goodwill-heavy.
The split is not just an accounting nicety. It directly affects the tax position of both buyer and seller, from capital gains relief on the seller's goodwill to capital allowances on the buyer's tangible assets. We explain how the allocation works and why it is negotiated in our breakdown of how much of a dental practice price is goodwill.
Secondary Methods and Sense-Checks
Two other approaches appear in dental valuations, but neither should drive the headline figure for a profitable trading practice.
Asset-Based Valuation
This method focuses on the practice's tangible assets, namely equipment, fixtures, fittings, and sometimes property. It is most relevant for a very new practice, a squat with little trading history, or a closure scenario where there is no meaningful goodwill to value.
The asset approach typically considers the depreciated current value of existing equipment, the replacement cost of equivalent kit, and, in a distressed situation, a forced-sale value. Used as a baseline it is fine, but it systematically undervalues a successful practice because it captures none of the goodwill, patient relationships, or earning power. For a busy, profitable surgery, an asset-only number is a floor, not a fair price.
Revenue and UDA Rules of Thumb (Why They Mislead)
You will still hear practices valued on a multiple of turnover, or on a price per UDA. These shortcuts are tempting because the inputs are easy to find, but they are unreliable as a primary method, and here is why.
Turnover and UDA count measure activity, not profit. Two practices billing the same fee income can deliver very different sustainable earnings once staff costs, associate fees, lab bills, materials, and premises are taken into account. A turnover multiple ignores the cost base entirely, so it flatters an inefficient practice and penalises a lean, well-run one. A price per UDA does the same thing for the NHS side, treating every contract as if the per-UDA value and the cost of delivering it were identical, which they are not.
That is the core reason the market has settled on normalised EBITDA. It values what the owner actually keeps. Treat any turnover or UDA figure as a rough sanity check on the EBITDA-based answer, never as the answer itself.
Common Valuation Pitfalls
Understanding where a valuation goes wrong helps you avoid costly mistakes on either side of a deal.
Owner-Dependent Earnings
If the practice's success rests on the seller's personal reputation and relationships, a buyer will worry about patient retention after completion, which compresses the multiple. Building systems and a stable team that reduce owner dependence improves both the multiple and the certainty of the sale.
Unadjusted Profit Figures
Aggressive profit extraction, family members on the payroll, or personal costs run through the practice can depress apparent profitability. These are legitimate arrangements, but they must be adjusted out during normalisation, otherwise the headline EBITDA understates the true earning power. The flip side is just as dangerous: a seller who has not paid themselves a market clinical rate can show an inflated EBITDA that a careful buyer will correct downwards. Sound profit extraction planning and a properly normalised set of figures protect you from both errors.
Anchoring to a Single Number
Valuation is part judgement, not pure arithmetic. Two advisers can reach different conclusions from the same accounts because they take different views on the multiple and the growth assumptions. Treating any one figure as gospel, whether it comes from a back-of-envelope turnover multiple or an optimistic projection, sets up a negotiation for disappointment. Work in ranges and understand what would move you within them.
Preparing Your Practice for Valuation
If a sale or valuation is on the horizon, some preparation can lift the result.
Get the financials clean. Work with your accountant so three years of comparable accounts clearly show sustainable profit. The easier it is to read a defensible normalised EBITDA, the stronger the multiple you can argue for.
Document the practice. Patient list and recall data, staff contracts, equipment records, the NHS contract, and the lease should all be organised and ready for a buyer's due diligence.
Address obvious weaknesses. Lease renewals, equipment repairs, or recruitment gaps are best resolved before the practice goes to market, because each one is a reason for a buyer to chip the multiple.
Reduce owner dependence. Anything that shows the earnings will survive your departure supports both the price and the certainty of completion.
Working with Valuers and Advisers
Choose advisers with specific dental experience. They understand the nuances of NHS contracts, UDA values, the goodwill split, and private patient dynamics that a generalist business valuer can miss. Be clear about the purpose, because a valuation for a sale can differ from one for a partnership buy-in, an estate, or tax planning.
Involve your accountant early so the financials are presented to best effect and the valuation approach aligns with your wider plans. If you want the full picture of how the pieces fit together, from normalised earnings through the multiple to the goodwill split and the tax outcome, our companion guide on how to value a UK dental practice in 2026 walks through a worked approach end to end.
Most of all, remember that the methods exist to support a judgement, not to replace it. A normalised EBITDA times a sensible, well-argued multiple, with goodwill and tangibles split correctly, is the foundation. Get that right and the rest of a sale, including the due diligence and the tax planning, has a solid number to build on.